wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38404422-1C0AC16A-053D-4B48-945B-5128704726D1
Q38404422-1C0AC16A-053D-4B48-945B-5128704726D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-1C0AC16A-053D-4B48-945B-5128704726D1
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
P2860
Q38404422-1C0AC16A-053D-4B48-945B-5128704726D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-1C0AC16A-053D-4B48-945B-5128704726D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38c4135fe57d9f81540a31d707b3606ba694db31
P2860
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up.